Lifevantage (NASDAQ:LFVN) Share Price Crosses Above Two Hundred Day Moving Average – Here’s What Happened

Shares of Lifevantage Corporation (NASDAQ:LFVN) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $5.72 and traded as high as $6.34. Lifevantage shares last traded at $6.20, with a volume of 89,958 shares.

Analysts Set New Price Targets

LFVN has been the topic of several recent analyst reports. Lake Street Capital lowered Lifevantage from a “buy” rating to a “hold” rating and set a $5.00 price target on the stock. in a research note on Thursday, May 7th. Weiss Ratings upgraded shares of Lifevantage from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, May 26th. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $5.00.

Lifevantage Trading Up 0.3%

The company has a market cap of $78.24 million, a P/E ratio of 13.78 and a beta of 0.73. The stock’s 50-day moving average price is $6.78 and its 200-day moving average price is $5.72.

Lifevantage (NASDAQ:LFVN) last issued its earnings results on Wednesday, May 6th. The company reported $0.12 EPS for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.04). Lifevantage had a net margin of 2.94% and a return on equity of 23.89%. The firm had revenue of $43.72 million during the quarter, compared to the consensus estimate of $47.77 million. On average, research analysts anticipate that Lifevantage Corporation will post 0.6 earnings per share for the current fiscal year.

Lifevantage Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were paid a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 3.2%. This is a boost from Lifevantage’s previous quarterly dividend of $0.04. The ex-dividend date of this dividend was Monday, June 1st. Lifevantage’s payout ratio is 44.44%.

Institutional Investors Weigh In On Lifevantage

Several hedge funds and other institutional investors have recently modified their holdings of the company. Bank of America Corp DE lifted its holdings in shares of Lifevantage by 24.3% in the 1st quarter. Bank of America Corp DE now owns 23,445 shares of the company’s stock worth $101,000 after purchasing an additional 4,586 shares in the last quarter. Bank of New York Mellon Corp grew its position in Lifevantage by 11.9% in the 1st quarter. Bank of New York Mellon Corp now owns 33,547 shares of the company’s stock valued at $145,000 after purchasing an additional 3,571 shares during the period. Hsbc Holdings PLC bought a new stake in Lifevantage during the 1st quarter valued at $51,000. DGS Capital Management LLC bought a new stake in Lifevantage during the 1st quarter valued at $44,000. Finally, Aristides Capital LLC acquired a new position in Lifevantage during the fourth quarter worth $76,000. Institutional investors own 35.32% of the company’s stock.

Lifevantage Company Profile

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.